| Primary |
| Stress Echocardiogram |
28.3% |
| Cardiac Stress Test |
21.7% |
| Coronary Artery Disease |
18.7% |
| Product Used For Unknown Indication |
10.8% |
| Cardiac Failure Congestive |
2.4% |
| High Frequency Ablation |
2.4% |
| Blood Pressure Management |
1.8% |
| Drug Use For Unknown Indication |
1.8% |
| Convulsion |
1.2% |
| Hypotension |
1.2% |
| Left Ventricular Dysfunction |
1.2% |
| Off Label Use |
1.2% |
| Positive Cardiac Inotropic Effect |
1.2% |
| Septic Shock |
1.2% |
| Syncope |
1.2% |
| Vasopressive Therapy |
1.2% |
| Angina Pectoris |
0.6% |
| Angina Unstable |
0.6% |
| Angiogram |
0.6% |
| Cardiac Disorder |
0.6% |
|
| Ventricular Tachycardia |
23.4% |
| Stress Cardiomyopathy |
20.2% |
| Atrial Fibrillation |
7.4% |
| Ventricular Fibrillation |
6.4% |
| Medication Error |
5.3% |
| Supraventricular Tachycardia |
5.3% |
| Convulsion |
4.3% |
| Hypertension |
4.3% |
| Acute Myocardial Infarction |
2.1% |
| Cardiac Arrest |
2.1% |
| Heart Rate Increased |
2.1% |
| Infusion Site Extravasation |
2.1% |
| Mitral Valve Incompetence |
2.1% |
| Myocardial Infarction |
2.1% |
| No Therapeutic Response |
2.1% |
| Phaeochromocytoma Crisis |
2.1% |
| Troponin T Increased |
2.1% |
| Vomiting |
2.1% |
| Aneurysm Ruptured |
1.1% |
| Blood Pressure Fluctuation |
1.1% |
|
| Secondary |
| Drug Use For Unknown Indication |
27.8% |
| Product Used For Unknown Indication |
16.2% |
| Cardiac Disorder |
8.0% |
| Vasodilatation |
8.0% |
| Cardiac Stress Test |
6.3% |
| Diagnostic Procedure |
3.4% |
| Sedation |
3.4% |
| Stress Echocardiogram |
3.4% |
| Cardiac Failure |
2.8% |
| Surgery |
2.8% |
| Pulmonary Hypertension |
2.6% |
| Analgesic Therapy |
2.3% |
| Cardiac Failure Congestive |
2.0% |
| Hypotension |
2.0% |
| Central Nervous System Leukaemia |
1.7% |
| Circulatory Collapse |
1.7% |
| Oliguria |
1.7% |
| Cardiogenic Shock |
1.4% |
| Myocardial Infarction |
1.4% |
| Cardiovascular Disorder |
1.1% |
|
| Toxic Epidermal Necrolysis |
17.5% |
| Disorientation |
10.5% |
| Hypertension |
8.8% |
| Hypotension |
8.8% |
| Supraventricular Tachycardia |
8.8% |
| Intestinal Ischaemia |
5.3% |
| Medication Error |
5.3% |
| Convulsion |
3.5% |
| Drug Ineffective |
3.5% |
| Eosinophilic Myocarditis |
3.5% |
| Hypokalaemia |
3.5% |
| Tumour Lysis Syndrome |
3.5% |
| Vasoconstriction |
3.5% |
| Ventricular Fibrillation |
3.5% |
| Aneurysm Ruptured |
1.8% |
| Anuria |
1.8% |
| Arthralgia |
1.8% |
| Atrial Fibrillation |
1.8% |
| Balance Disorder |
1.8% |
| Bronchospasm |
1.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
48.7% |
| Drug Use For Unknown Indication |
24.9% |
| Coronary Artery Bypass |
5.3% |
| Prophylaxis |
2.0% |
| Acute Myocardial Infarction |
1.8% |
| Pulmonary Arterial Hypertension |
1.7% |
| Sedation |
1.7% |
| Aortic Valve Replacement |
1.5% |
| Hypertension |
1.3% |
| Catheterisation Cardiac |
1.2% |
| Cardiac Failure |
1.1% |
| Ventricular Tachycardia |
1.1% |
| Atrial Fibrillation |
1.1% |
| Myocardial Infarction |
1.1% |
| Analgesic Effect |
1.0% |
| Hypotension |
1.0% |
| Cardiac Failure Congestive |
1.0% |
| Mitral Valve Repair |
0.9% |
| Ventricular Assist Device Insertion |
0.9% |
| Mitral Valve Replacement |
0.8% |
|
| Injury |
10.1% |
| Pain |
9.8% |
| Unevaluable Event |
8.7% |
| Fear |
8.5% |
| Renal Failure |
4.9% |
| Renal Impairment |
4.9% |
| Respiratory Failure |
4.9% |
| Vomiting |
4.9% |
| Anhedonia |
4.6% |
| Multi-organ Failure |
4.4% |
| Ventricular Fibrillation |
4.4% |
| Septic Shock |
3.8% |
| Sepsis |
3.6% |
| Emotional Distress |
3.3% |
| Renal Injury |
3.3% |
| Stress |
3.3% |
| Systemic Inflammatory Response Syndrome |
3.3% |
| Ventricular Tachycardia |
3.3% |
| Anxiety |
3.0% |
| Death |
3.0% |
|
| Interacting |
| Product Used For Unknown Indication |
42.9% |
| Cardiac Disorder |
14.3% |
| Psychotic Disorder |
14.3% |
| Cardiac Failure Congestive |
7.1% |
| Off Label Use |
7.1% |
| Stress Echocardiogram |
7.1% |
| Syncope |
7.1% |
|
| Drug Interaction |
75.0% |
| Myoclonus |
25.0% |
|
